Trending Now
Titan Pharmaceuticals Inc. (NASDAQ: TTNP) Receives Funding To Advance HIV Therapy...
Titan Pharmaceuticals Inc. (NASDAQ: TTNP) has received financing from the Bill and Melinda Gates Foundation supporting the demonstration of its capability to produce a...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
SINTX Technologies (SINT) Secures Key Patent, Solidifies Leadership in Advanced Ceramics
SINTX Technologies, Inc. (NASDAQ: SINT), a frontrunner in ceramic manufacturing, recently announced a significant victory in its pursuit of innovation: the United...
MAKE IT MODERN
LATEST REVIEWS
PTC Therapeutics, Inc. (NASDAQ:PTCT) Receives the First Milestone Payment from a...
The founding of PTC Therapeutics, Inc. (NASDAQ:PTCT), Inc over 20 years ago was driven by the need to create: a patient-centric approach to treating...
MAKE IT MODERN
PERFORMANCE TRAINING
How Pot Stocks Shape Up in H2 2020 (TLRY, LHSIF, NUGS, CURLF, APHA)
The notion that cannabis producers are now moving into ascendency once again in the stock market is not necessarily original as of last month,...
Diffusion Pharmaceuticals Inc (NASDAQ:DFFN) Submits IND filing For TSC In Preparation For Phase 1b/2b...
Diffusion Pharmaceuticals Inc (NASDAQ:DFFN) recently announced that it submitted an Investigational New Drug (IND) application filing to the Food and Drug Administration for trans...
Mind Medicine (MindMed) Inc (NASDAQ: MNMD) Doses First Patient on Phase 2b MM-120 Study...
Mind Medicine (MindMed) Inc (NASDAQ: MNMD) has announced the dosing of the first patient in the Phase 2b dose-optimization study of MM-120 for Generalized...
Onconova Therapeutics Inc. (NASDAQ:ONTX) Commence Enrolment in Phase 1/2a Rigosertib Plus Nivolumab Study in...
Onconova Therapeutics Inc. (NASDAQ:ONTX) has enrolled in Phase 1/2a oral rigosertib, and nivolumab study in advanced metastatic KRAS mutated lung adenocarcinoma.
KRAS mutation main genetic...
Three Stocks to Target the Testing Test (ABT, ALST, QDEL)
It’s all about testing. Short of a vaccine, testing is the high-margin investment from a social survival standpoint for the whole system. Testing, testing,...
MAKE IT MODERN
